Veterinary Infusion Pumps Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Large Volume Infusion Pumps, Syringe Infusion Pumps), By End User (Private Hospitals, Private Clinics, Teaching Hospitals), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 312.45 MIllion
CAGR (2026-2031)	7.24%
Fastest Growing Segment	Syringe Infusion Pump
Largest Market	North America
Market Size (2031)	USD 475.25 MIllion

Market Overview

The Global Veterinary Infusion Pumps Market will grow from USD 312.45 MIllion in 2025 to USD 475.25 MIllion by 2031 at a 7.24% CAGR. Veterinary infusion pumps are medical devices designed to deliver fluids, medications, and nutrients to animals in precise and controlled volumes. The market is primarily driven by the escalating global pet population and a concurrent rise in expenditure on animal healthcare services. This growth is further supported by the increasing prevalence of chronic animal diseases requiring long-term fluid therapy and the humanization of pets which prompts owners to seek enhanced medical treatments. According to the American Pet Products Association, in 2024, total U.S. pet industry expenditures reached $152 billion. This financial commitment highlights the growing demand for higher standards of veterinary care including fluid management technologies.

Despite these positive indicators, the market faces a significant restraint regarding the high acquisition and maintenance costs associated with modern infusion systems. Smaller veterinary clinics often struggle with these capital requirements which limits the widespread adoption of such technology in developing regions or budget-constrained practices.

Key Market Drivers

The rising prevalence of chronic and age-related veterinary diseases is a primary catalyst for the widespread adoption of infusion pumps in animal healthcare. As companion animals live longer, they are increasingly susceptible to complex conditions such as renal failure, cancer, and diabetes, all of which frequently necessitate precise fluid management and long-term medication delivery. Obesity significantly exacerbates these health risks, leading to a higher volume of surgical interventions and critical care requirements where automated infusion systems are essential for patient safety. According to the Association for Pet Obesity Prevention, April 2025, in the '2024 Pet Obesity & Nutrition Opinion Survey', 35% of dog owners and 33% of cat owners reported their pets were overweight or had obesity. This substantial prevalence of weight-related health issues directly correlates with the growing demand for sophisticated therapeutic equipment to manage the resulting medical complications.

The expansion of pet insurance coverage and healthcare expenditure plays a crucial role in making these advanced veterinary treatments financially accessible to a broader demographic. With a financial safety net in place, pet owners are more inclined to opt for costly procedures, including continuous infusion therapies and post-operative critical care, which were previously cost-prohibitive. This trend is evident in the robust growth of the insurance sector; according to the North American Pet Health Insurance Association, April 2025, in the 'State of the Industry Report 2025', the total number of insured pets in North America reached 7.03 million at the end of 2024. Furthermore, the financial scale of this support is immense; according to the Association of British Insurers, in 2025, total pet insurance payouts reached a record £1.23 billion for the previous year. This increasing financial backing empowers veterinary facilities to invest in high-quality infusion pumps to meet the elevated standards of care demanded by insured clients.

Download Free Sample Report

Key Market Challenges

The high acquisition and maintenance costs associated with modern veterinary infusion systems constitute a substantial barrier to market expansion. Advanced infusion pumps, while offering precise fluid delivery and improved patient safety, require a significant upfront capital investment that many smaller or independent veterinary clinics find difficult to justify. Beyond the initial purchase price, these devices often necessitate ongoing expenditures for specialized consumables, regular calibration, and technical maintenance, which further strains the operational budgets of veterinary practices. Consequently, this financial burden forces many budget-constrained facilities to rely on manual fluid administration methods or older equipment, thereby stalling the widespread adoption of advanced technology.

This economic pressure is evidenced by recent industry financial performance metrics which highlight the fiscal challenges faced by practices. According to the American Veterinary Medical Association, in 2024, the average gross revenue per full-time equivalent veterinarian was approximately $554,982, a figure that represents a decline in inflation-adjusted terms compared to previous benchmarks. This tightening of real revenue limits the discretionary capital available for practice upgrades. When veterinary clinics face stagnating purchasing power, they are compelled to deprioritize investments in expensive medical devices like infusion pumps, directly hampering the overall growth of the global market.

Key Market Trends

The integration of wireless connectivity and IoT capabilities is fundamentally reshaping the Global Veterinary Infusion Pumps Market by addressing the acute need for operational efficiency within veterinary practices. Clinics are increasingly adopting smart infusion systems that automatically synchronize treatment data with electronic medical records, thereby reducing manual entry errors and freeing staff for patient care. These connected devices allow for remote monitoring of fluid delivery, ensuring safety while optimizing workflow in understaffed facilities. This drive toward digital optimization is substantiated by industry sentiment; according to Covetrus, July 2024, in the 'Top Veterinary Industry Trends to Watch in 2024 and Beyond' report, over 80% of veterinary professionals confirmed they are actively prioritizing the optimization of their practice technology to alleviate administrative burdens.

Simultaneously, the expansion of home-based veterinary infusion therapy is emerging as a critical trend, spurred by the rising costs of advanced inpatient treatments. Veterinary facilities are deploying compact, ambulatory infusion pumps that enable pet owners to manage long-term therapies, such as chemotherapy or pain management, in a comfortable home environment. This shift allows for earlier patient discharge, effectively bridging the gap between necessary medical protocols and affordability. This trend is largely a response to economic pressures on pet owners; according to Synchrony, October 2024, in the 'Veterinary Specialty Care Study', 72% of pet parents indicated they are very or extremely concerned about the financial implications of specialty veterinary care, driving the market demand for more affordable outpatient delivery systems.

Segmental Insights

The Syringe Infusion Pump segment is recognized as the fastest-growing category within the Global Veterinary Infusion Pumps Market due to its essential role in administering precise, low-volume medication to small companion animals. These devices are increasingly preferred in veterinary clinics for critical care and anesthesia scenarios where accurate dosage regulation is vital for patient safety, particularly for smaller species and neonates. Consequently, the rising prevalence of complex medical treatments requiring strict fluid management drives the accelerated adoption of these precise delivery systems over traditional volumetric alternatives.

Regional Insights

North America holds a dominant position in the global veterinary infusion pumps market, primarily driven by high pet ownership rates and substantial expenditure on animal healthcare. The region benefits from a robust infrastructure of veterinary hospitals and specialty clinics that prioritize precise fluid administration. This leadership is further strengthened by the widespread availability of pet health insurance, which allows owners to afford specialized medical treatments. Additionally, the presence of major manufacturers and adherence to practice standards referenced by the American Veterinary Medical Association supports the continued adoption of these devices across the region.

Recent Developments

• In September 2024, Patterson Companies Inc. announced the acquisition of Infusion Concepts Ltd., a United Kingdom-based specialist in veterinary infusion therapy. Through this strategic transaction, Patterson’s animal health subsidiary, National Veterinary Services Limited (NVS), absorbed a market leader recognized for its design and supply of species-specific infusion pumps, drainage systems, and critical care products. This acquisition significantly strengthens Patterson's portfolio in the Global Veterinary Infusion Pumps Market, allowing the company to enhance its distribution of specialized fluid management solutions to veterinary professionals and expand its presence in the international animal health sector.
• In September 2024, Mindray Animal Medical officially launched its "Orange Label" series of veterinary medical devices at the 49th World Small Animal Veterinary Association (WSAVA) Congress held in Suzhou, China. The newly introduced product line includes the AniFM i1 Veterinary Infusion Pump, which features advanced technologies such as tube fatigue compensation and intelligent occlusion management designed specifically for animal care. This product launch highlights the company's commitment to delivering comprehensive fluid management solutions that address the dynamic needs of veterinary clinics, enhancing both the safety and efficiency of infusion therapy in daily practice.
• In April 2024, Baxter International Inc., a prominent manufacturer whose devices are widely utilized in the veterinary sector, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Novum IQ large volume infusion pump. This regulatory milestone allows the company to introduce an advanced infusion platform equipped with the Dose IQ Safety Software, which is designed to reduce programming errors and improve operational efficiency. The availability of this next-generation technology is relevant to the Global Veterinary Infusion Pumps Market, as it offers veterinary teaching hospitals and critical care facilities access to high-standard fluid delivery systems with enhanced connectivity.
• In February 2024, Covetrus was successfully re-awarded a position on the Advanced Procurement for Universities and Colleges (APUC) Veterinary Supplies Framework Agreement. This significant commercial collaboration involves the supply of a wide range of veterinary essentials, including pharmaceutical products and medical equipment such as infusion pumps, to higher education and research institutions across the United Kingdom. This agreement reinforces the company's status as a key distributor in the market, ensuring that academic veterinary facilities are equipped with the latest fluid therapy technologies to support both teaching applications and clinical research.

Key Market Players

• B. Braun Melsungen AG
• HESKA Corporation
• Burtons Medical Equipment Ltd
• Digicare Biomedical Technology, Inc
• Dre Veterinary, Inc.
• Grady Medical Systems, Inc.
• Jorgen Kruuse A/S
• Jorgensen Laboratories
• Leading Edge Veterinary Equipment
• Q Core Medical Ltd

By Type	By End User	By Region
Large Volume Infusion Pumps Syringe Infusion Pumps	Private Hospitals Private Clinics Teaching Hospitals	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Veterinary Infusion Pumps Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Veterinary Infusion Pumps Market , By Type:

• Large Volume Infusion Pumps
• Syringe Infusion Pumps

• Veterinary Infusion Pumps Market , By End User:

• Private Hospitals
• Private Clinics
• Teaching Hospitals

• Veterinary Infusion Pumps Market , By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE